Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
P 4 (2)

Trial Status

Withdrawn2
Enrolling By Invitation1
Active Not Recruiting1
Recruiting1
Unknown1

Clinical Trials (6)

Research Network

Activity Timeline